Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
29
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Singh Vanila | Director | 25 | $0 | $0 | 2022-03-22 |
| Vollins James | See Remarks | 45 | $0 | $543.6K | 2022-03-22 |
| Smith Thomas B | Chief Medical Officer | 28 | $0 | $15.7K | 2022-03-22 |
| Plesha Scott M. | See Remarks | 60 | $0 | $677.1K | 2022-03-22 |
| Watson W. Mark | Director | 19 | $0 | $67.3K | 2022-03-22 |
| Golubieski John | See Remarks | 5 | $0 | $0 | 2022-03-22 |
| Broadfin Capital, LLC | Director | 22 | $320.0K | $21.80M | 2022-03-22 |
| Bailey Jeffrey Allen | Director | 30 | $0 | $43.5K | 2022-03-22 |
| Davis Todd C | Director | 22 | $0 | $1.47M | 2022-03-22 |
| Greenleaf Peter | Director | 18 | $0 | $0 | 2022-03-22 |
| Sirgo Mark A | See Remarks | 150 | $316.6K | $13.26M | 2022-03-22 |
| Broadfin Healthcare Master Fund Ltd | Director | 10 | $960.5K | $23.91M | 2022-02-11 |
| KOTLER KEVIN | Director | 14 | $1.20M | $10.00M | 2021-11-19 |
| Coelho Mary Theresa | See Remarks | 17 | $0 | $292.6K | 2021-02-01 |
| ODONNELL FRANCIS E JR | Director, 10% Owner | 153 | $0 | $9.52M | 2020-05-11 |
| Cukier Herm | Chief Executive Officer | 18 | $0 | $580.1K | 2020-05-04 |
| De Paolantonio Ernest Robert | See Remarks | 42 | $35.8K | $314.7K | 2018-12-04 |
| SEARS SAMUEL P JR | Director | 32 | $0 | $333.5K | 2017-11-15 |
| Feinberg Barry I | Director | 30 | $90.7K | $0 | 2017-08-14 |
| D'Alonzo Thomas | Director | 24 | $75.2K | $0 | 2017-08-14 |
| Bramlage Charles | Director | 19 | $49.9K | $0 | 2017-08-14 |
| TYSON TIMOTHY | Director | 4 | $0 | $0 | 2017-08-14 |
| STONE WILLIAM B | Director | 52 | $0 | $1.99M | 2017-08-14 |
| Vasisht Niraj | See Remarks | 29 | $2.8K | $211.7K | 2017-03-23 |
| Shea John J | Director | 48 | $0 | $2.14M | 2015-08-13 |
| Finn Andrew L | Executive Vice President | 30 | $35.2K | $4.38M | 2015-06-15 |
| MCNULTY JAMES A | SVP Finance & Treasurer | 51 | $22.5K | $1.64M | 2014-01-24 |
| Poole William | Director | 4 | $0 | $48.0K | 2013-08-14 |
| WARD BENNY | EVP of Busi. & Strategic Dev. | 2 | $0 | $0 | 2012-02-15 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Bailey Jeffrey Allen | Chief Executive Officer | D To issuer deriv | 2022-03-22 | 2022-03-22 | 840,000 | — | $0 | 0 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | D To issuer deriv | 2022-03-22 | 2022-03-22 | 66,805 | — | $0 | 0 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | D To issuer deriv | 2022-03-22 | 2022-03-22 | 160,000 | — | $0 | 0 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | D To issuer deriv | 2022-03-22 | 2022-03-22 | 96,000 | — | $0 | 0 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | D To issuer deriv | 2022-03-22 | 2022-03-22 | 316,919 | — | $0 | 0 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | D To issuer deriv | 2022-03-22 | 2022-03-22 | 1,143,467 | — | $0 | 0 | SEC↗ |
| Davis Todd C | Director | D To issuer deriv | 2022-03-22 | 2022-03-22 | 22,685 | — | $0 | 0 | SEC↗ |
| Davis Todd C | Director | D To issuer deriv | 2022-03-22 | 2022-03-22 | 48,123 | — | $0 | 0 | SEC↗ |
| Davis Todd C | Director | D To issuer deriv | 2022-03-22 | 2022-03-22 | 85,760 | — | $0 | 0 | SEC↗ |
| Greenleaf Peter | Director | D To issuer deriv | 2022-03-22 | 2022-03-22 | 27,746 | — | $0 | 0 | SEC↗ |
| Greenleaf Peter | Director | D To issuer deriv | 2022-03-22 | 2022-03-22 | 114,347 | — | $0 | 0 | SEC↗ |
| Greenleaf Peter | Director | D To issuer deriv | 2022-03-22 | 2022-03-22 | 64,164 | — | $0 | 0 | SEC↗ |
| Golubieski John | See Remarks | D To issuer deriv | 2022-03-22 | 2022-03-22 | 373,533 | — | $0 | 0 | SEC↗ |
| Golubieski John | See Remarks | D To issuer deriv | 2022-03-22 | 2022-03-22 | 333,133 | — | $0 | 0 | SEC↗ |
| Golubieski John | See Remarks | D To issuer deriv | 2022-03-22 | 2022-03-22 | 126,199 | — | $0 | 0 | SEC↗ |
| Broadfin Capital, LLC | Director | D To issuer deriv | 2022-03-22 | 2022-03-22 | 22,685 | — | $0 | 0 | SEC↗ |
| Broadfin Capital, LLC | Director | D To issuer deriv | 2022-03-22 | 2022-03-22 | 7,500 | — | $0 | 0 | SEC↗ |
| Broadfin Capital, LLC | Director | D To issuer deriv | 2022-03-22 | 2022-03-22 | 85,760 | — | $0 | 0 | SEC↗ |
| Plesha Scott M. | See Remarks | D To issuer deriv | 2022-03-22 | 2022-03-22 | 369,721 | — | $0 | 0 | SEC↗ |
| Plesha Scott M. | See Remarks | D To issuer deriv | 2022-03-22 | 2022-03-22 | 348,222 | — | $0 | 0 | SEC↗ |
| Plesha Scott M. | See Remarks | D To issuer deriv | 2022-03-22 | 2022-03-22 | 119,228 | — | $0 | 0 | SEC↗ |
| Plesha Scott M. | See Remarks | D To issuer deriv | 2022-03-22 | 2022-03-22 | 245,000 | — | $0 | 0 | SEC↗ |
| Sirgo Mark A | Director | D To issuer deriv | 2022-03-22 | 2022-03-22 | 85,760 | — | $0 | 0 | SEC↗ |
| Sirgo Mark A | Director | D To issuer deriv | 2022-03-22 | 2022-03-22 | 48,000 | — | $0 | 0 | SEC↗ |
| Sirgo Mark A | Director | D To issuer deriv | 2022-03-22 | 2022-03-22 | 11,685 | — | $0 | 0 | SEC↗ |
| Sirgo Mark A | Director | D To issuer deriv | 2022-03-22 | 2022-03-22 | 48,000 | — | $0 | 0 | SEC↗ |
| Sirgo Mark A | Director | D To issuer deriv | 2022-03-22 | 2022-03-22 | 22,500 | — | $0 | 0 | SEC↗ |
| Smith Thomas B | Chief Medical Officer | D To issuer deriv | 2022-03-22 | 2022-03-22 | 130,000 | — | $0 | 0 | SEC↗ |
| Smith Thomas B | Chief Medical Officer | D To issuer deriv | 2022-03-22 | 2022-03-22 | 117,691 | — | $0 | 0 | SEC↗ |
| Smith Thomas B | Chief Medical Officer | D To issuer deriv | 2022-03-22 | 2022-03-22 | 88,719 | — | $0 | 0 | SEC↗ |
| Smith Thomas B | Chief Medical Officer | D To issuer deriv | 2022-03-22 | 2022-03-22 | 259,186 | — | $0 | 0 | SEC↗ |
| Smith Thomas B | Chief Medical Officer | D To issuer deriv | 2022-03-22 | 2022-03-22 | 287,194 | — | $0 | 0 | SEC↗ |
| Singh Vanila | Director | D To issuer deriv | 2022-03-22 | 2022-03-22 | 17,019 | — | $0 | 0 | SEC↗ |
| Singh Vanila | Director | D To issuer deriv | 2022-03-22 | 2022-03-22 | 85,760 | — | $0 | 0 | SEC↗ |
| Singh Vanila | Director | D To issuer deriv | 2022-03-22 | 2022-03-22 | 48,000 | — | $0 | 0 | SEC↗ |
| Singh Vanila | Director | D To issuer deriv | 2022-03-22 | 2022-03-22 | 81,008 | — | $0 | 0 | SEC↗ |
| Vollins James | See Remarks | D To issuer deriv | 2022-03-22 | 2022-03-22 | 43,334 | — | $0 | 0 | SEC↗ |
| Vollins James | See Remarks | D To issuer deriv | 2022-03-22 | 2022-03-22 | 29,826 | — | $0 | 0 | SEC↗ |
| Vollins James | See Remarks | D To issuer deriv | 2022-03-22 | 2022-03-22 | 91,401 | — | $0 | 0 | SEC↗ |
| Vollins James | See Remarks | D To issuer deriv | 2022-03-22 | 2022-03-22 | 269,244 | — | $0 | 0 | SEC↗ |
| Vollins James | See Remarks | D To issuer deriv | 2022-03-22 | 2022-03-22 | 82,508 | — | $0 | 0 | SEC↗ |
| Vollins James | See Remarks | D To issuer deriv | 2022-03-22 | 2022-03-22 | 282,055 | — | $0 | 0 | SEC↗ |
| Watson W. Mark | Director | D To issuer deriv | 2022-03-22 | 2022-03-22 | 22,685 | — | $0 | 0 | SEC↗ |
| Watson W. Mark | Director | D To issuer deriv | 2022-03-22 | 2022-03-22 | 54,740 | — | $0 | 0 | SEC↗ |
| Watson W. Mark | Director | D To issuer deriv | 2022-03-22 | 2022-03-22 | 85,760 | — | $0 | 0 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | J Other | 2022-03-22 | 2022-03-22 | 105,133 | — | $0 | 0 | SEC↗ |
| Davis Todd C | Director | J Other | 2022-03-22 | 2022-03-22 | 252,207 | — | $0 | 0 | SEC↗ |
| Greenleaf Peter | Director | J Other | 2022-03-22 | 2022-03-22 | 105,034 | — | $0 | 0 | SEC↗ |
| Broadfin Capital, LLC | Director | J Other | 2022-03-22 | 2022-03-22 | 7,588,395 | — | $0 | 0 | SEC↗ |
| Plesha Scott M. | See Remarks | J Other | 2022-03-22 | 2022-03-22 | 345,127 | — | $0 | 0 | SEC↗ |
| Sirgo Mark A | Director | J Other | 2022-03-22 | 2022-03-22 | 1,166,866 | — | $0 | 0 | SEC↗ |
| Smith Thomas B | Chief Medical Officer | J Other | 2022-03-22 | 2022-03-22 | 52,530 | — | $0 | 0 | SEC↗ |
| Singh Vanila | Director | J Other | 2022-03-22 | 2022-03-22 | 35,851 | — | $0 | 0 | SEC↗ |
| Watson W. Mark | Director | J Other | 2022-03-22 | 2022-03-22 | 90,663 | — | $0 | 0 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | M Exercise deriv | 2022-03-09 | 2022-03-11 | 5,333 | — | $0 | 5,334 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | M Exercise | 2022-03-09 | 2022-03-11 | 5,333 | — | $0 | 105,133 | SEC↗ |
| Broadfin Healthcare Master Fun | Director | C Conversion deriv | 2022-02-11 | 2022-02-15 | 436 | $10000.00 | $4.36M | 0 | SEC↗ |
| Broadfin Healthcare Master Fun | Director | C Conversion | 2022-02-11 | 2022-02-15 | 2,422,222 | $1.80 | $4.36M | 7,588,395 | SEC↗ |
| Vollins James | See Remarks | S Sale | 2022-02-04 | 2022-02-08 | 18,541 | $3.60 | $66.7K | 9,872 | SEC↗ |
| Vollins James | See Remarks | F Tax w/h | 2022-02-04 | 2022-02-08 | 9,872 | $3.66 | $36.1K | 0 | SEC↗ |
| Plesha Scott M. | See Remarks | M Exercise deriv | 2022-01-31 | 2022-01-31 | 13,334 | — | $0 | 0 | SEC↗ |
| Vollins James | See Remarks | M Exercise deriv | 2022-01-31 | 2022-01-31 | 3,834 | — | $0 | 0 | SEC↗ |
| Smith Thomas B | Chief Medical Officer | M Exercise deriv | 2022-01-31 | 2022-01-31 | 7,667 | — | $0 | 0 | SEC↗ |
| Plesha Scott M. | See Remarks | M Exercise | 2022-01-31 | 2022-01-31 | 10,869 | — | $0 | 331,793 | SEC↗ |
| Plesha Scott M. | See Remarks | M Exercise | 2022-01-31 | 2022-01-31 | 13,334 | — | $0 | 345,127 | SEC↗ |
| Vollins James | See Remarks | M Exercise | 2022-01-31 | 2022-01-31 | 8,303 | — | $0 | 24,579 | SEC↗ |
| Vollins James | See Remarks | M Exercise | 2022-01-31 | 2022-01-31 | 3,834 | — | $0 | 28,413 | SEC↗ |
| Smith Thomas B | Chief Medical Officer | M Exercise | 2022-01-31 | 2022-01-31 | 7,667 | — | $0 | 52,530 | SEC↗ |
| Smith Thomas B | Chief Medical Officer | M Exercise | 2022-01-31 | 2022-01-31 | 7,548 | — | $0 | 44,863 | SEC↗ |
| Plesha Scott M. | See Remarks | M Exercise deriv | 2022-01-29 | 2022-01-31 | 10,869 | — | $0 | 10,870 | SEC↗ |
| Vollins James | See Remarks | M Exercise deriv | 2022-01-29 | 2022-01-31 | 8,303 | — | $0 | 8,303 | SEC↗ |
| Smith Thomas B | Chief Medical Officer | M Exercise deriv | 2022-01-29 | 2022-01-31 | 7,548 | — | $0 | 7,549 | SEC↗ |
| Plesha Scott M. | See Remarks | M Exercise deriv | 2022-01-27 | 2022-01-31 | 21,050 | — | $0 | 42,101 | SEC↗ |
| Plesha Scott M. | See Remarks | A Award deriv | 2022-01-27 | 2022-01-31 | 369,721 | $3.66 | $1.35M | 369,721 | SEC↗ |
| Plesha Scott M. | See Remarks | A Award deriv | 2022-01-27 | 2022-01-31 | 66,257 | — | $0 | 66,257 | SEC↗ |
| Vollins James | See Remarks | M Exercise deriv | 2022-01-27 | 2022-01-31 | 16,276 | — | $0 | 32,552 | SEC↗ |
| Vollins James | See Remarks | A Award deriv | 2022-01-27 | 2022-01-31 | 282,055 | — | $0 | 282,055 | SEC↗ |
| Vollins James | See Remarks | A Award deriv | 2022-01-27 | 2022-01-31 | 50,546 | — | $0 | 50,546 | SEC↗ |
| Smith Thomas B | Chief Medical Officer | A Award deriv | 2022-01-27 | 2022-01-31 | 46,448 | — | $0 | 46,448 | SEC↗ |
| Smith Thomas B | Chief Medical Officer | A Award deriv | 2022-01-27 | 2022-01-31 | 259,186 | $3.66 | $948.6K | 259,186 | SEC↗ |
| Smith Thomas B | Chief Medical Officer | M Exercise deriv | 2022-01-27 | 2022-01-31 | 17,361 | — | $0 | 34,722 | SEC↗ |
| Golubieski John | See Remarks | A Award deriv | 2022-01-27 | 2022-01-31 | 66,940 | — | $0 | 66,940 | SEC↗ |
| Golubieski John | See Remarks | A Award deriv | 2022-01-27 | 2022-01-31 | 373,533 | $3.66 | $1.37M | 373,533 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | A Award deriv | 2022-01-27 | 2022-01-31 | 1,143,467 | $3.66 | $4.19M | 1,143,467 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | A Award deriv | 2022-01-27 | 2022-01-31 | 204,918 | — | $0 | 204,918 | SEC↗ |
| Greenleaf Peter | Director | A Award deriv | 2022-01-27 | 2022-01-31 | 114,347 | $3.66 | $418.5K | 114,347 | SEC↗ |
| Greenleaf Peter | Director | A Award deriv | 2022-01-27 | 2022-01-31 | 20,492 | — | $0 | 20,492 | SEC↗ |
| Greenleaf Peter | Director | M Exercise deriv | 2022-01-27 | 2022-01-31 | 10,246 | — | $0 | 10,246 | SEC↗ |
| Broadfin Capital, LLC | Director | A Award deriv | 2022-01-27 | 2022-01-31 | 15,369 | — | $0 | 15,369 | SEC↗ |
| Broadfin Capital, LLC | Director | M Exercise deriv | 2022-01-27 | 2022-01-31 | 7,684 | — | $0 | 7,685 | SEC↗ |
| Broadfin Capital, LLC | Director | A Award deriv | 2022-01-27 | 2022-01-31 | 85,760 | — | $0 | 85,760 | SEC↗ |
| Sirgo Mark A | Director | A Award deriv | 2022-01-27 | 2022-01-31 | 15,369 | — | $0 | 15,369 | SEC↗ |
| Sirgo Mark A | Director | A Award deriv | 2022-01-27 | 2022-01-31 | 85,760 | — | $0 | 85,760 | SEC↗ |
| Sirgo Mark A | Director | M Exercise deriv | 2022-01-27 | 2022-01-31 | 7,684 | — | $0 | 7,685 | SEC↗ |
| Singh Vanila | Director | A Award deriv | 2022-01-27 | 2022-01-31 | 85,760 | — | $0 | 85,760 | SEC↗ |
| Singh Vanila | Director | A Award deriv | 2022-01-27 | 2022-01-31 | 15,369 | — | $0 | 15,369 | SEC↗ |
| Singh Vanila | Director | M Exercise deriv | 2022-01-27 | 2022-01-31 | 7,684 | — | $0 | 7,685 | SEC↗ |
| Watson W. Mark | Director | M Exercise deriv | 2022-01-27 | 2022-01-31 | 7,684 | — | $0 | 7,685 | SEC↗ |
| Watson W. Mark | Director | A Award deriv | 2022-01-27 | 2022-01-31 | 15,369 | — | $0 | 15,369 | SEC↗ |
| Watson W. Mark | Director | A Award deriv | 2022-01-27 | 2022-01-31 | 85,760 | $3.66 | $313.9K | 85,760 | SEC↗ |
| Davis Todd C | Director | M Exercise deriv | 2022-01-27 | 2022-02-01 | 7,684 | — | $0 | 7,685 | SEC↗ |
| Davis Todd C | Director | A Award deriv | 2022-01-27 | 2022-02-01 | 15,369 | — | $0 | 15,369 | SEC↗ |
| Davis Todd C | Director | A Award deriv | 2022-01-27 | 2022-02-01 | 85,760 | $3.66 | $313.9K | 85,760 | SEC↗ |
| Plesha Scott M. | See Remarks | M Exercise | 2022-01-27 | 2022-01-31 | 21,050 | — | $0 | 320,924 | SEC↗ |
| Vollins James | See Remarks | M Exercise | 2022-01-27 | 2022-01-31 | 16,276 | — | $0 | 16,276 | SEC↗ |
| Smith Thomas B | Chief Medical Officer | M Exercise | 2022-01-27 | 2022-01-31 | 17,361 | — | $0 | 37,315 | SEC↗ |
| Greenleaf Peter | Director | M Exercise | 2022-01-27 | 2022-01-31 | 10,246 | — | $0 | 105,034 | SEC↗ |
| Broadfin Capital, LLC | Director | M Exercise | 2022-01-27 | 2022-01-31 | 7,684 | — | $0 | 5,166,173 | SEC↗ |
| Sirgo Mark A | Director | M Exercise | 2022-01-27 | 2022-01-31 | 7,684 | — | $0 | 1,166,866 | SEC↗ |
| Singh Vanila | Director | M Exercise | 2022-01-27 | 2022-01-31 | 7,684 | — | $0 | 35,851 | SEC↗ |
| Watson W. Mark | Director | M Exercise | 2022-01-27 | 2022-01-31 | 7,684 | — | $0 | 90,663 | SEC↗ |
| Davis Todd C | Director | M Exercise | 2022-01-27 | 2022-02-01 | 7,684 | — | $0 | 252,207 | SEC↗ |
| Vollins James | See Remarks | A Award deriv | 2022-01-17 | 2022-01-19 | 82,508 | $3.03 | $250.0K | 82,508 | SEC↗ |
| Sirgo Mark A | Director | P Buy | 2021-12-02 | 2021-12-06 | 18,587 | $2.69 | $50.0K | 1,159,182 | SEC↗ |
| Singh Vanila | Director | M Exercise deriv | 2021-11-22 | 2021-11-23 | 5,333 | — | $0 | 5,334 | SEC↗ |
| Singh Vanila | Director | M Exercise | 2021-11-22 | 2021-11-23 | 5,333 | — | $0 | 28,167 | SEC↗ |
| KOTLER KEVIN | Director | P Buy | 2021-11-19 | 2021-11-22 | 100,000 | $3.06 | $306.0K | 5,158,489 | SEC↗ |
| Sirgo Mark A | Director | S Sale | 2021-11-18 | 2021-11-19 | 10,000 | $3.04 | $30.4K | 1,140,595 | SEC↗ |
| Sirgo Mark A | Director | P Buy | 2021-11-18 | 2021-11-19 | 10,000 | $3.04 | $30.4K | 1,140,595 | SEC↗ |
| Broadfin Capital, LLC | Director | P Buy | 2021-11-12 | 2021-11-15 | 100,000 | $3.20 | $320.0K | 5,058,489 | SEC↗ |
| Sirgo Mark A | Director | P Buy | 2021-11-11 | 2021-11-12 | 16,000 | $3.20 | $51.2K | 1,130,595 | SEC↗ |
| KOTLER KEVIN | Director | P Buy | 2021-11-05 | 2021-11-09 | 257,800 | $3.47 | $894.6K | 4,958,489 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | M Exercise deriv | 2021-11-04 | 2021-11-08 | 53,333 | — | $0 | 106,667 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | M Exercise | 2021-11-04 | 2021-11-08 | 53,333 | — | $0 | 99,800 | SEC↗ |
| Sirgo Mark A | Director | M Exercise deriv | 2021-08-23 | 2021-08-25 | 4,000 | — | $0 | 4,000 | SEC↗ |
| Sirgo Mark A | Director | A Award deriv | 2021-08-23 | 2021-08-25 | 48,000 | $3.76 | $180.5K | 48,000 | SEC↗ |
| Sirgo Mark A | Director | A Award deriv | 2021-08-23 | 2021-08-25 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Singh Vanila | Director | A Award deriv | 2021-08-23 | 2021-08-25 | 48,000 | $3.76 | $180.5K | 48,000 | SEC↗ |
| Singh Vanila | Director | A Award deriv | 2021-08-23 | 2021-08-25 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Singh Vanila | Director | M Exercise deriv | 2021-08-23 | 2021-08-25 | 4,000 | — | $0 | 4,000 | SEC↗ |
| Sirgo Mark A | Director | M Exercise | 2021-08-23 | 2021-08-25 | 4,000 | — | $0 | 1,114,595 | SEC↗ |
| Singh Vanila | Director | M Exercise | 2021-08-23 | 2021-08-25 | 4,000 | — | $0 | 22,834 | SEC↗ |
| KOTLER KEVIN | Director | C Conversion deriv | 2021-08-10 | 2021-08-10 | 15,000 | $2.93 | $44.0K | 7,500 | SEC↗ |
| KOTLER KEVIN | Director | M Exercise | 2021-08-10 | 2021-08-10 | 15,000 | $2.93 | $44.0K | 4,700,689 | SEC↗ |
| Davis Todd C | Director | M Exercise deriv | 2021-08-06 | 2021-08-10 | 30,000 | — | $0 | 15,000 | SEC↗ |
| Greenleaf Peter | Director | M Exercise deriv | 2021-08-06 | 2021-08-10 | 35,000 | — | $0 | 17,500 | SEC↗ |
| KOTLER KEVIN | Director | M Exercise deriv | 2021-08-06 | 2021-08-10 | 30,000 | — | $0 | 15,000 | SEC↗ |
| Watson W. Mark | Director | M Exercise deriv | 2021-08-06 | 2021-08-10 | 30,000 | — | $0 | 15,000 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | M Exercise deriv | 2021-08-06 | 2021-08-10 | 5,567 | — | $0 | 0 | SEC↗ |
| Sirgo Mark A | Director | M Exercise deriv | 2021-08-06 | 2021-08-10 | 4,000 | — | $0 | 0 | SEC↗ |
| Singh Vanila | Director | M Exercise deriv | 2021-08-06 | 2021-08-10 | 6,750 | — | $0 | 0 | SEC↗ |
| Davis Todd C | Director | M Exercise | 2021-08-06 | 2021-08-10 | 30,000 | — | $0 | 244,523 | SEC↗ |
| Greenleaf Peter | Director | M Exercise | 2021-08-06 | 2021-08-10 | 35,000 | — | $0 | 94,788 | SEC↗ |
| KOTLER KEVIN | Director | M Exercise | 2021-08-06 | 2021-08-10 | 30,000 | — | $0 | 4,685,689 | SEC↗ |
| Watson W. Mark | Director | M Exercise | 2021-08-06 | 2021-08-10 | 30,000 | — | $0 | 82,979 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | M Exercise | 2021-08-06 | 2021-08-10 | 5,567 | — | $0 | 46,467 | SEC↗ |
| Sirgo Mark A | Director | M Exercise | 2021-08-06 | 2021-08-10 | 4,000 | — | $0 | 1,110,595 | SEC↗ |
| Singh Vanila | Director | M Exercise | 2021-08-06 | 2021-08-10 | 6,750 | — | $0 | 18,834 | SEC↗ |
| Sirgo Mark A | Director | P Buy | 2021-05-13 | 2021-05-13 | 3,000 | $3.16 | $9.5K | 1,106,595 | SEC↗ |
| Broadfin Healthcare Master Fun | Director | P Buy | 2021-05-13 | 2021-05-13 | 50,000 | $3.25 | $162.5K | 4,655,689 | SEC↗ |
| Sirgo Mark A | Director | P Buy | 2021-05-12 | 2021-05-13 | 5,000 | $3.24 | $16.2K | 1,103,595 | SEC↗ |
| Broadfin Healthcare Master Fun | Director | P Buy | 2021-05-12 | 2021-05-13 | 100,000 | $3.24 | $324.0K | 4,605,689 | SEC↗ |
| Sirgo Mark A | Director | P Buy | 2021-05-11 | 2021-05-13 | 7,500 | $3.16 | $23.7K | 1,098,595 | SEC↗ |
| Broadfin Healthcare Master Fun | Director | P Buy | 2021-05-11 | 2021-05-13 | 150,000 | $3.16 | $474.0K | 4,505,689 | SEC↗ |
| Plesha Scott M. | See Remarks | M Exercise deriv | 2021-03-12 | 2021-03-16 | 20,834 | — | $0 | 0 | SEC↗ |
| Plesha Scott M. | See Remarks | M Exercise | 2021-03-12 | 2021-03-16 | 20,834 | — | $0 | 299,874 | SEC↗ |
| Plesha Scott M. | See Remarks | A Award | 2021-03-12 | 2021-03-16 | 20,834 | — | $0 | 279,040 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | M Exercise deriv | 2021-03-09 | 2021-03-11 | 5,333 | — | $0 | 10,667 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | M Exercise | 2021-03-09 | 2021-03-11 | 5,333 | — | $0 | 40,900 | SEC↗ |
| Vollins James | See Remarks | S Sale | 2021-02-08 | 2021-02-08 | 3,833 | $4.16 | $15.9K | 0 | SEC↗ |
| Vollins James | See Remarks | S Sale | 2021-02-04 | 2021-02-08 | 8,303 | $3.97 | $33.0K | 3,833 | SEC↗ |
| Smith Thomas B | Chief Medical Officer | M Exercise deriv | 2021-02-01 | 2021-02-02 | 7,667 | — | $0 | 7,667 | SEC↗ |
| Vollins James | See Remarks | M Exercise deriv | 2021-02-01 | 2021-02-02 | 3,833 | — | $0 | 3,834 | SEC↗ |
| Plesha Scott M. | See Remarks | M Exercise deriv | 2021-02-01 | 2021-02-02 | 13,333 | — | $0 | 13,334 | SEC↗ |
| Smith Thomas B | Chief Medical Officer | M Exercise | 2021-02-01 | 2021-02-02 | 7,667 | — | $0 | 19,954 | SEC↗ |
| Vollins James | See Remarks | M Exercise | 2021-02-01 | 2021-02-02 | 3,833 | — | $0 | 12,136 | SEC↗ |
| Plesha Scott M. | See Remarks | M Exercise | 2021-02-01 | 2021-02-02 | 13,333 | — | $0 | 258,206 | SEC↗ |
| Coelho Mary Theresa | See Remarks | S Sale | 2021-02-01 | 2021-02-02 | 3,460 | $3.87 | $13.4K | 30,619 | SEC↗ |
| Smith Thomas B | Chief Medical Officer | M Exercise deriv | 2021-01-29 | 2021-02-02 | 7,548 | — | $0 | 15,097 | SEC↗ |
| Vollins James | See Remarks | M Exercise deriv | 2021-01-29 | 2021-02-02 | 8,303 | — | $0 | 16,606 | SEC↗ |
| Plesha Scott M. | See Remarks | M Exercise deriv | 2021-01-29 | 2021-02-02 | 10,870 | — | $0 | 21,739 | SEC↗ |
| Coelho Mary Theresa | See Remarks | M Exercise deriv | 2021-01-29 | 2021-02-02 | 10,190 | — | $0 | 20,381 | SEC↗ |
| Smith Thomas B | Chief Medical Officer | M Exercise | 2021-01-29 | 2021-02-02 | 7,548 | — | $0 | 12,287 | SEC↗ |
| Vollins James | See Remarks | M Exercise | 2021-01-29 | 2021-02-02 | 8,303 | — | $0 | 8,303 | SEC↗ |
| Plesha Scott M. | See Remarks | M Exercise | 2021-01-29 | 2021-02-02 | 10,870 | — | $0 | 244,873 | SEC↗ |
| Coelho Mary Theresa | See Remarks | M Exercise | 2021-01-29 | 2021-02-02 | 10,190 | — | $0 | 34,079 | SEC↗ |
| Plesha Scott M. | See Remarks | A Award deriv | 2021-01-27 | 2021-01-29 | 63,151 | — | $0 | 63,151 | SEC↗ |
| Plesha Scott M. | See Remarks | A Award deriv | 2021-01-27 | 2021-01-29 | 348,222 | — | $0 | 348,222 | SEC↗ |
| Smith Thomas B | Chief Medical Officer | A Award deriv | 2021-01-27 | 2021-01-29 | 287,194 | — | $0 | 287,194 | SEC↗ |
| Smith Thomas B | Chief Medical Officer | A Award deriv | 2021-01-27 | 2021-01-29 | 52,083 | — | $0 | 52,083 | SEC↗ |
| Coelho Mary Theresa | See Remarks | A Award deriv | 2021-01-27 | 2021-01-29 | 344,632 | — | $0 | 344,632 | SEC↗ |
| Coelho Mary Theresa | See Remarks | A Award deriv | 2021-01-27 | 2021-01-29 | 62,500 | — | $0 | 62,500 | SEC↗ |
| Vollins James | See Remarks | A Award deriv | 2021-01-27 | 2021-01-29 | 269,244 | — | $0 | 269,244 | SEC↗ |
| Vollins James | See Remarks | A Award deriv | 2021-01-27 | 2021-01-29 | 48,828 | — | $0 | 48,828 | SEC↗ |
| Coelho Mary Theresa | See Remarks | S Sale | 2021-01-19 | 2021-01-20 | 6,462 | $4.32 | $27.9K | 23,889 | SEC↗ |
| Coelho Mary Theresa | See Remarks | M Exercise deriv | 2021-01-15 | 2021-01-20 | 18,333 | — | $0 | 18,334 | SEC↗ |
| Coelho Mary Theresa | See Remarks | M Exercise | 2021-01-15 | 2021-01-20 | 18,333 | — | $0 | 30,351 | SEC↗ |
| Vollins James | See Remarks | M Exercise deriv | 2020-12-16 | 2020-12-16 | 9,505 | $3.46 | $32.9K | 29,826 | SEC↗ |
| Vollins James | See Remarks | S Sale | 2020-12-16 | 2020-12-16 | 9,505 | $4.48 | $42.6K | 0 | SEC↗ |
| Vollins James | See Remarks | M Exercise | 2020-12-16 | 2020-12-16 | 9,505 | $3.46 | $32.9K | 9,505 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | S Sale | 2020-12-15 | 2020-12-16 | 10,000 | $4.35 | $43.5K | 35,567 | SEC↗ |
| Vollins James | See Remarks | M Exercise deriv | 2020-12-14 | 2020-12-16 | 20,320 | $3.46 | $70.3K | 39,331 | SEC↗ |
| Vollins James | See Remarks | M Exercise | 2020-12-14 | 2020-12-16 | 20,320 | $3.46 | $70.3K | 20,320 | SEC↗ |
| Vollins James | See Remarks | S Sale | 2020-12-14 | 2020-12-16 | 20,320 | $4.46 | $90.6K | 0 | SEC↗ |
| Singh Vanila | Director | M Exercise deriv | 2020-11-23 | 2020-11-27 | 5,333 | — | $0 | 10,667 | SEC↗ |
| Singh Vanila | Director | M Exercise | 2020-11-23 | 2020-11-27 | 5,333 | — | $0 | 12,084 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | M Exercise deriv | 2020-11-04 | 2020-11-06 | 40,000 | — | $0 | 0 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | A Award deriv | 2020-11-04 | 2020-11-06 | 840,000 | — | $0 | 840,000 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | A Award deriv | 2020-11-04 | 2020-11-06 | 160,000 | — | $0 | 160,000 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | M Exercise | 2020-11-04 | 2020-11-06 | 40,000 | — | $0 | 45,567 | SEC↗ |
| Davis Todd C | Director | S Sale | 2020-08-18 | 2020-08-20 | 50,000 | $4.99 | $249.5K | 217,914 | SEC↗ |
| Watson W. Mark | Director | S Sale | 2020-08-17 | 2020-08-19 | 13,000 | $5.18 | $67.3K | 52,979 | SEC↗ |
| Sirgo Mark A | Director | S Sale | 2020-08-14 | 2020-08-17 | 115,000 | $4.90 | $563.5K | 1,091,095 | SEC↗ |
| Sirgo Mark A | Director | S Sale | 2020-08-13 | 2020-08-17 | 85,000 | $4.53 | $385.1K | 1,206,095 | SEC↗ |
| Davis Todd C | Director | M Exercise deriv | 2020-08-07 | 2020-08-11 | 30,000 | — | $0 | 45,000 | SEC↗ |
| Watson W. Mark | Director | M Exercise deriv | 2020-08-07 | 2020-08-11 | 30,000 | — | $0 | 45,000 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | M Exercise deriv | 2020-08-07 | 2020-08-11 | 5,567 | — | $0 | 5,567 | SEC↗ |
| Singh Vanila | Director | M Exercise deriv | 2020-08-07 | 2020-08-11 | 6,751 | — | $0 | 6,750 | SEC↗ |
| Sirgo Mark A | Director | M Exercise deriv | 2020-08-07 | 2020-08-11 | 4,000 | — | $0 | 4,000 | SEC↗ |
| Greenleaf Peter | Director | M Exercise deriv | 2020-08-07 | 2020-08-11 | 35,000 | — | $0 | 52,500 | SEC↗ |
| KOTLER KEVIN | Director | M Exercise deriv | 2020-08-07 | 2020-08-11 | 30,000 | — | $0 | 45,000 | SEC↗ |
| KOTLER KEVIN | Director | C Conversion deriv | 2020-08-07 | 2020-08-11 | 15,000 | — | $0 | 22,500 | SEC↗ |
| Davis Todd C | Director | M Exercise | 2020-08-07 | 2020-08-11 | 30,000 | — | $0 | 267,914 | SEC↗ |
| Watson W. Mark | Director | M Exercise | 2020-08-07 | 2020-08-11 | 30,000 | — | $0 | 65,979 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | M Exercise | 2020-08-07 | 2020-08-11 | 5,567 | — | $0 | 5,567 | SEC↗ |
| Singh Vanila | Director | M Exercise | 2020-08-07 | 2020-08-11 | 6,751 | — | $0 | 6,751 | SEC↗ |
| Sirgo Mark A | Director | M Exercise | 2020-08-07 | 2020-08-11 | 4,000 | — | $0 | 1,291,095 | SEC↗ |
| Greenleaf Peter | Director | M Exercise | 2020-08-07 | 2020-08-11 | 35,000 | — | $0 | 59,788 | SEC↗ |
| KOTLER KEVIN | Director | M Exercise | 2020-08-07 | 2020-08-11 | 15,000 | $2.93 | $44.0K | 4,355,689 | SEC↗ |
| KOTLER KEVIN | Director | M Exercise | 2020-08-07 | 2020-08-11 | 30,000 | — | $0 | 4,340,689 | SEC↗ |
| Singh Vanila | Director | A Award deriv | 2020-07-30 | 2020-08-03 | 81,008 | $4.36 | $353.2K | 81,008 | SEC↗ |
| Singh Vanila | Director | A Award deriv | 2020-07-30 | 2020-08-03 | 13,501 | — | $0 | 13,501 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | A Award deriv | 2020-07-30 | 2020-08-03 | 11,134 | — | $0 | 11,134 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | A Award deriv | 2020-07-30 | 2020-08-03 | 66,805 | — | $0 | 66,805 | SEC↗ |
| Sirgo Mark A | Director | A Award deriv | 2020-07-30 | 2020-08-03 | 48,000 | — | $0 | 48,000 | SEC↗ |
| Sirgo Mark A | Director | A Award deriv | 2020-07-30 | 2020-08-03 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Vollins James | See Remarks | M Exercise deriv | 2020-05-21 | 2020-05-22 | 21,666 | $3.90 | $84.5K | 43,334 | SEC↗ |
| Vollins James | See Remarks | M Exercise | 2020-05-21 | 2020-05-22 | 21,666 | $3.90 | $84.5K | 21,666 | SEC↗ |
| Vollins James | See Remarks | S Sale | 2020-05-21 | 2020-05-22 | 21,666 | $4.60 | $99.7K | 0 | SEC↗ |
| Plesha Scott M. | See Remarks | S Sale | 2020-05-18 | 2020-05-20 | 15,000 | $4.52 | $67.8K | 234,003 | SEC↗ |
| Sirgo Mark A | Director | M Exercise deriv | 2020-05-11 | 2020-05-12 | 22,500 | — | $0 | 0 | SEC↗ |
| ODONNELL FRANCIS E JR | Director | M Exercise deriv | 2020-05-11 | 2020-05-14 | 22,500 | — | $0 | 0 | SEC↗ |
| Sirgo Mark A | Director | M Exercise | 2020-05-11 | 2020-05-12 | 22,500 | — | $0 | 1,287,095 | SEC↗ |
| ODONNELL FRANCIS E JR | Director | M Exercise | 2020-05-11 | 2020-05-14 | 22,500 | — | $0 | 628,038 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | A Award deriv | 2020-05-10 | 2020-05-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Bailey Jeffrey Allen | Chief Executive Officer | A Award deriv | 2020-05-10 | 2020-05-12 | 160,000 | — | $0 | 160,000 | SEC↗ |
| Sirgo Mark A | Director | S Sale | 2020-05-08 | 2020-05-12 | 100,000 | $5.07 | $507.0K | 1,264,595 | SEC↗ |
| ODONNELL FRANCIS E JR | Director | S Sale | 2020-05-06 | 2020-05-08 | 11,250 | $4.53 | $51.0K | 605,538 | SEC↗ |
| Cukier Herm | Chief Executive Officer | M Exercise deriv | 2020-05-04 | 2020-05-05 | 66,666 | — | $0 | 66,668 | SEC↗ |
| Cukier Herm | Chief Executive Officer | M Exercise | 2020-05-04 | 2020-05-05 | 66,666 | — | $0 | 102,447 | SEC↗ |
| ODONNELL FRANCIS E JR | Director | S Sale | 2020-05-04 | 2020-05-05 | 16,000 | $4.45 | $71.2K | 616,788 | SEC↗ |
| Sirgo Mark A | Director | S Sale | 2020-04-27 | 2020-04-29 | 100,000 | $4.58 | $458.0K | 1,364,595 | SEC↗ |
| ODONNELL FRANCIS E JR | Director | S Sale | 2020-04-20 | 2020-04-22 | 20,000 | $4.22 | $84.4K | 632,788 | SEC↗ |
| Sirgo Mark A | Director | S Sale | 2020-04-15 | 2020-04-17 | 50,000 | $4.13 | $206.5K | 1,464,595 | SEC↗ |
| Plesha Scott M. | See Remarks | S Sale | 2020-03-18 | 2020-03-18 | 15,000 | $3.55 | $53.3K | 249,003 | SEC↗ |
| Broadfin Capital, LLC | Director | C Conversion deriv | 2020-03-17 | 2020-03-19 | 10,623 | — | $0 | 37,500 | SEC↗ |
| ODONNELL FRANCIS E JR | Director | S Sale | 2020-03-17 | 2020-03-18 | 30,500 | $3.63 | $110.7K | 656,072 | SEC↗ |
| Broadfin Capital, LLC | Director | M Exercise | 2020-03-17 | 2020-03-19 | 10,623 | $2.93 | $31.1K | 4,310,689 | SEC↗ |
| ODONNELL FRANCIS E JR | Director | M Exercise deriv | 2020-03-16 | 2020-03-18 | 15,000 | — | $0 | 0 | SEC↗ |
| ODONNELL FRANCIS E JR | Director | M Exercise deriv | 2020-03-16 | 2020-03-18 | 62,500 | — | $0 | 0 | SEC↗ |
| Plesha Scott M. | See Remarks | M Exercise deriv | 2020-03-16 | 2020-03-18 | 20,833 | — | $0 | 0 | SEC↗ |
| Plesha Scott M. | See Remarks | M Exercise deriv | 2020-03-16 | 2020-03-18 | 8,334 | — | $0 | 0 | SEC↗ |
| Sirgo Mark A | Director | A Award | 2020-03-16 | 2020-03-18 | 36,471 | — | $0 | 1,514,595 | SEC↗ |
| ODONNELL FRANCIS E JR | Director | S Sale | 2020-03-16 | 2020-03-18 | 38,750 | $3.60 | $139.5K | 686,572 | SEC↗ |
| ODONNELL FRANCIS E JR | Director | A Award | 2020-03-16 | 2020-03-18 | 18,284 | — | $0 | 725,322 | SEC↗ |
| ODONNELL FRANCIS E JR | Director | A Award | 2020-03-16 | 2020-03-18 | 15,000 | — | $0 | 700,470 | SEC↗ |
| ODONNELL FRANCIS E JR | Director | M Exercise | 2020-03-16 | 2020-03-18 | 62,500 | — | $0 | 611,254 | SEC↗ |
| ODONNELL FRANCIS E JR | Director | M Exercise | 2020-03-16 | 2020-03-18 | 15,000 | — | $0 | 688,754 | SEC↗ |
| ODONNELL FRANCIS E JR | Director | A Award | 2020-03-16 | 2020-03-18 | 62,500 | — | $0 | 673,754 | SEC↗ |
| Plesha Scott M. | See Remarks | A Award | 2020-03-16 | 2020-03-18 | 20,833 | — | $0 | 264,003 | SEC↗ |
| Plesha Scott M. | See Remarks | M Exercise | 2020-03-16 | 2020-03-18 | 20,833 | — | $0 | 243,170 | SEC↗ |
| Plesha Scott M. | See Remarks | A Award | 2020-03-16 | 2020-03-18 | 8,334 | — | $0 | 222,337 | SEC↗ |
| Plesha Scott M. | See Remarks | M Exercise | 2020-03-16 | 2020-03-18 | 8,334 | — | $0 | 214,003 | SEC↗ |
| Vollins James | See Remarks | S Sale | 2020-03-16 | 2020-03-18 | 3,833 | $3.50 | $13.4K | 0 | SEC↗ |
| Bailey Jeffrey Allen | Director | A Award deriv | 2020-03-09 | 2020-03-17 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Bailey Jeffrey Allen | Director | A Award deriv | 2020-03-09 | 2020-03-17 | 96,000 | — | $0 | 96,000 | SEC↗ |
| ODONNELL FRANCIS E JR | Director | S Sale | 2020-02-03 | 2020-02-04 | 8,000 | $5.31 | $42.5K | 548,754 | SEC↗ |
| Cukier Herm | Chief Executive Officer | S Sale | 2020-02-03 | 2020-02-04 | 31,850 | $5.16 | $164.3K | 35,781 | SEC↗ |
| Vollins James | See Remarks | M Exercise deriv | 2020-01-31 | 2020-02-04 | 3,833 | — | $0 | 7,667 | SEC↗ |
| Cukier Herm | Chief Executive Officer | M Exercise deriv | 2020-01-31 | 2020-02-04 | 31,250 | — | $0 | 62,500 | SEC↗ |
| Plesha Scott M. | See Remarks | M Exercise deriv | 2020-01-31 | 2020-02-04 | 13,333 | — | $0 | 26,667 | SEC↗ |
| Smith Thomas B | Chief Medical Officer | M Exercise deriv | 2020-01-31 | 2020-02-04 | 7,666 | — | $0 | 15,334 | SEC↗ |
| Vollins James | See Remarks | M Exercise | 2020-01-31 | 2020-02-04 | 3,833 | — | $0 | 3,833 | SEC↗ |
| Cukier Herm | Chief Executive Officer | M Exercise | 2020-01-31 | 2020-02-04 | 31,250 | — | $0 | 67,631 | SEC↗ |
| Plesha Scott M. | See Remarks | M Exercise | 2020-01-31 | 2020-02-04 | 13,333 | — | $0 | 205,669 | SEC↗ |
| Smith Thomas B | Chief Medical Officer | M Exercise | 2020-01-31 | 2020-02-04 | 7,666 | — | $0 | 7,666 | SEC↗ |
| Smith Thomas B | Chief Medical Officer | S Sale | 2020-01-31 | 2020-02-04 | 2,927 | $5.38 | $15.7K | 4,739 | SEC↗ |
| Smith Thomas B | Chief Medical Officer | A Award deriv | 2020-01-29 | 2020-01-31 | 22,645 | — | $0 | 22,645 | SEC↗ |
| Smith Thomas B | Chief Medical Officer | A Award deriv | 2020-01-29 | 2020-01-31 | 110,122 | — | $0 | 110,122 | SEC↗ |
| Coelho Mary Theresa | See Remarks | A Award deriv | 2020-01-29 | 2020-01-31 | 30,571 | — | $0 | 30,571 | SEC↗ |
| Coelho Mary Theresa | See Remarks | A Award deriv | 2020-01-29 | 2020-01-31 | 148,665 | — | $0 | 148,665 | SEC↗ |
| Plesha Scott M. | See Remarks | A Award deriv | 2020-01-29 | 2020-01-31 | 32,609 | — | $0 | 32,609 | SEC↗ |
| Plesha Scott M. | See Remarks | A Award deriv | 2020-01-29 | 2020-01-31 | 158,576 | — | $0 | 158,576 | SEC↗ |
| Cukier Herm | Chief Executive Officer | A Award deriv | 2020-01-29 | 2020-01-31 | 440,490 | — | $0 | 440,490 | SEC↗ |
| Cukier Herm | Chief Executive Officer | A Award deriv | 2020-01-29 | 2020-01-31 | 90,580 | — | $0 | 90,580 | SEC↗ |
| Vollins James | See Remarks | A Award deriv | 2020-01-29 | 2020-01-31 | 24,909 | — | $0 | 24,909 | SEC↗ |
| Vollins James | See Remarks | A Award deriv | 2020-01-29 | 2020-01-31 | 121,135 | — | $0 | 121,135 | SEC↗ |
| Plesha Scott M. | See Remarks | S Sale | 2020-01-21 | 2020-01-23 | 15,000 | $5.77 | $86.5K | 192,336 | SEC↗ |
| Coelho Mary Theresa | See Remarks | S Sale | 2020-01-16 | 2020-01-17 | 42,018 | $5.98 | $251.3K | 12,018 | SEC↗ |
| Coelho Mary Theresa | See Remarks | M Exercise deriv | 2020-01-15 | 2020-01-17 | 35,703 | $3.73 | $133.2K | 71,406 | SEC↗ |
| Coelho Mary Theresa | See Remarks | M Exercise deriv | 2020-01-15 | 2020-01-17 | 18,333 | — | $0 | 36,667 | SEC↗ |
| Coelho Mary Theresa | See Remarks | M Exercise | 2020-01-15 | 2020-01-17 | 18,333 | — | $0 | 18,333 | SEC↗ |
| Coelho Mary Theresa | See Remarks | M Exercise | 2020-01-15 | 2020-01-17 | 35,703 | $3.73 | $133.2K | 54,036 | SEC↗ |
| Sirgo Mark A | Director | S Sale | 2020-01-07 | 2020-01-09 | 13,353 | $5.65 | $75.4K | 1,478,124 | SEC↗ |
| Sirgo Mark A | Director | S Sale | 2020-01-06 | 2020-01-06 | 18,600 | $5.84 | $108.6K | 1,491,477 | SEC↗ |
| Sirgo Mark A | Director | S Sale | 2020-01-03 | 2020-01-06 | 13,857 | $6.00 | $83.1K | 1,510,077 | SEC↗ |
| ODONNELL FRANCIS E JR | Director | S Sale | 2020-01-02 | 2020-01-03 | 8,000 | $6.10 | $48.8K | 556,754 | SEC↗ |
| Sirgo Mark A | Director | S Sale | 2020-01-02 | 2020-01-06 | 54,190 | $6.09 | $330.0K | 1,523,934 | SEC↗ |
| ODONNELL FRANCIS E JR | Director | M Exercise deriv | 2019-12-26 | 2019-12-31 | 10,000 | — | $0 | 0 | SEC↗ |
| ODONNELL FRANCIS E JR | Director | S Sale | 2019-12-26 | 2019-12-30 | 10,000 | $7.00 | $70.0K | 554,754 | SEC↗ |